Ignite Creation Date:
2024-05-06 @ 12:51 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03863223
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-11-23
First Post:
2019-03-01
Brief Title:
A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer
Sponsor:
Organization:
Jiangsu HengRui Medicine Co Ltd